In particular, for patients with osteoporosis who are unresponsive to or intolerant of other drugs, an anabolic agent, 1–34 PTH or teriparatide [74], which has been shown to increase osseointegration of implants, may be used. The gene discussed is PTH; the disease is osteoporosis.